Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study

The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK

(2016) Wrik Ghosh et al.   ADVANCES IN THERAPY

Distinguishing between Better and Worse Visual Acuity by Studying the Correlation with Quality of Life in Neovascular Age-Related Macular Degeneration

(2016) Mari Elshout et al.   OPHTHALMOLOGY

Longitudinal Changes in Quality of Life and Rates of Progressive Visual Field Loss in Glaucoma Patients

(2015) Felipe A. Medeiros et al.   OPHTHALMOLOGY

Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges

(2015) Jordana K. Schmier et al.   PHARMACOECONOMICS

The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters

(2014) Mari Elshout et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Modeling Complex Treatment Strategies: Construction and Validation of a Discrete Event Simulation Model for Glaucoma

(2010) Aukje van Gestel et al.   VALUE IN HEALTH

Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial

(2009) Peter K. Kaiser et al.   CURRENT MEDICAL RESEARCH AND OPINION

Natural History of Predominantly Classic, Minimally Classic, and Occult Subgroups in Exudative Age-related Macular Degeneration

(2009) Ankoor R. Shah et al.   OPHTHALMOLOGY

The burden of multiple sclerosis: A community health survey

(2008) C Allyson Jones et al.   Health and Quality of Life Outcomes

The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration

(2007) Tien Wong et al.   OPHTHALMOLOGY